At the 11th biennial meeting of the International Gynecologic Cancer Society (IGCS) underway in Santa Monica, CA, the potential impact of widespread adoption of HPV vaccination among girls in Mexico was described. In a study, “HPV-Vaccination Impact on Cervical Cancer Incidence and Mortality in Mexico: A Cancer Registry Based Model,” a team from the Mexican Institute of Social Security (Instituto Mexicano Del Seguro Social), the Mexican Institute of Public Health (Instituto Nacional de Salud Publica) and GlaxoSmithKline (GSK) concluded that HPV vaccination targeting HPV subtypes 16 and 18 could reduce cervical cancer cases and deaths by 60 percent.